Page 11 - Health Sector

India achieves target to eliminate visceral leishmaniasis 'Kala-Azar'

As per the WHO, in 2020, India accounted for 18 per cent of the global burden of kala-azar

A malignant concern: India is fast emerging world's cancer capital

The report sheds light on the concerning rise of non-communicable diseases (NCDs) in India, including cancer, diabetes, hypertension, cardiovascular diseases, and mental health issues

Prices of essential medicines will not be increased in FY25: Mandaviya

Union Minister Mansukh Mandaviya said on Thursday said there will be no increase in prices of essential medicines this fiscal year in view of negligible growth in wholesale price-based inflation. In an interaction with PTI editors at the news agency's headquarters here, Mandaviya -- the Union Chemicals and Fertilisers Minister -- assured that this is "Modiji's guarantee". When asked about reports and speculations of hike in rates of essential drugs, he said, "It is absolutely incorrect. There will be no increase in the price of medicines". The minister said the National Pharmaceutical Pricing Authority (NPPA), which is under the Department of Pharmaceuticals, annually revises the ceiling prices of scheduled medicines on the basis of Wholesale Price Index (WPI). "NPPA monitors and fixes the prices of essential medicines based on WPI," Mandaviya said. When inflation rises, it leads to a hike in prices and when it goes down, the prices come down, the minister said. "This year the ..

General Atlantic acquires majority stake in Ujala Cygnus hospitals

Ujala Cygnus currently operates 21 hospitals in five states of northern India, catering mainly to tier-2 and tier-3 cities

Aurobindo's Eugia recalls pain-relieving injection Methocarbamol in US

The recall comes after a consumer complained about possible contamination

Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines

Bilthoven Biologicals will produce the vaccines for distribution in India and worldwide

Govt mandates linking of CGHS and ABHA IDs to integrate health schemes

The CGHS scheme provides comprehensive healthcare services to central government employees, pensioners, and their dependent family members

CAR-T cell therapy raising hopes for cancer patients, medical tourism

CAR-T therapy is seen to be on the verge of a breakthrough, raising hopes for both cancer patients as well as medical tourism. But can it become the first line of treatment?

Aster DM's deal to separate India and GCC businesses nears completion

In November 2023, Aster DM had received corporate approvals to separate its India and Gulf Cooperation Council (GCC) businesses into two distinct and standalone entities

2K doctors from India to plug UK's national health service shortage

Doctors in India view this move as temporary, citing the high number of doctors produced in the country each year

Centre forms committee to look into Ayushman Bharat implementation

A key task of the committee is to suggest measures to prevent fraud or misuse of the scheme

Entod Pharmaceuticals develops human insulin eye drops to treat corneal eye

Recent research suggests that insulin eye drops can be effective in repairing corneal tissue and treating ocular surface conditions

Max Healthcare and Touch Healthcare signs agreement to settle dispute

Max Healthcare accused Touch Healthcare of favouring Blackstone's offer over a prior agreement for Care Hospitals' sale

A wiser world after Covid

Another pandemic or global scale disaster is inevitable but the Covid experience will help us deal with it better

Healthcare innovation to double at $60 bn opportunity by FY28 in India

Indian vaccines and biotech market, which was valued at $4 billion in FY23, accounting for 15 percent of the innovation market, has quickly grown from $1.2 billion in FY20

Double-blind trial soon for Ayush drugs to treat anaemia in women

The ministry on Monday tied up with the Indian Council of Medical Research (ICMR) to conduct the study, which aims at backing up Ayush treatment with scientific and evidence-based research

'Two-thirds of greenfield units under PLI for bulk drugs completed'

Union Minister of Chemical and Fertilisers Mansukh Mandaviya on Saturday inaugurated 40 greenfield facilities to manufacture bulk drugs and medical devices under the PLI scheme

Biocon Biologics gets green light to launch Yesafili biosimilar in Canada

Under the agreement, Biocon Biologics will launch Yesafili no later than July 1, 2025. Health Canada had granted tentative approval for Yesafili in March 2023

Major hospital chains report increase in average revenue per occupied bed

The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years

Pfizer, Niper collaborate to support healthcare startups in India

The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad